Wockhardt, Jemincare associate for novel respiration antibiotic Nafithromycin

Wockhardt, Jemincare associate for novel respiration antibiotic Nafithromycin

by admin- Thursday, August 26th, 2021 03:38:51 PM

Wockhardt Bio AG – a subsidiary of Wockhardt have partnered for Wockhardt’s novel patented antibiotic WCK 4873 in People’s Republic of China, Hong Kong, Macau and Taiwan for the treatment of community-acquired bacterial pneumonia and other breathing tract infections.

News Updates